View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AF43 | Publication ID: Fall 2017 |
Title: Sunscreen Drug Products For Over-The-Counter-Human Use; Tentative Final Monograph | ||
Abstract:
|
||
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant | |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage | |
Major: Yes | Unfunded Mandates: No | |
EO 13771 Designation: Deregulatory | ||
CFR Citation: 21 CFR 201 21 CFR 310 21 CFR 330 to 358 | ||
Legal Authority: 21 U.S.C. 321p 21 U.S.C. 331 21 U.S.C. 351 to 353 21 U.S.C. 355 21 U.S.C. 360 21 U.S.C. 371 |
Legal Deadline:
None |
|||||||||||||||||||||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Yes | Government Levels Affected: Local, State |
Small Entities Affected: Businesses | Federalism: Yes |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: Yes | |
Related RINs: Split from 0910-AA01 | |
Agency Contact: Sharon Colemsn Regulatory Counsel Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, WO 22, Room 6212, 10903 New Hampshire Avenue, Silver Spring, MD 20993 Phone:301 796-2490 Fax:301 796-9899 Email: sharon.coleman@fda.hhs.gov |